Tivic Health Systems (NASDAQ:TIVC) Announces Earnings Results

Tivic Health Systems (NASDAQ:TIVCGet Rating) announced its quarterly earnings results on Monday. The company reported ($0.23) earnings per share for the quarter, reports. The business had revenue of $0.43 million for the quarter.

Shares of TIVC stock traded up $0.11 during trading on Thursday, reaching $1.72. The company’s stock had a trading volume of 87 shares, compared to its average volume of 107,308. The firm’s fifty day moving average is $1.59. Tivic Health Systems has a one year low of $1.23 and a one year high of $6.50.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC acquired a new position in shares of Tivic Health Systems in the first quarter valued at about $197,000. Schonfeld Strategic Advisors LLC acquired a new stake in Tivic Health Systems during the fourth quarter worth about $42,000. BlackRock Inc. acquired a new stake in Tivic Health Systems during the fourth quarter worth about $35,000. Finally, Kepos Capital LP bought a new position in shares of Tivic Health Systems in the fourth quarter worth about $233,000. 1.31% of the stock is currently owned by hedge funds and other institutional investors.

Tivic Health Systems Company Profile (Get Rating)

Tivic Health Systems Inc operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S.

See Also

Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.